Medicare Enrolled
Dr. Manuel Ybarra, MD
Anesthesiology · Schertz, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ybarra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ybarra?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ybarra
Dr. Manuel Ybarra is an anesthesiology specialist in Schertz, TX, with 17 years of NPI registration. Based on federal Medicare data, Dr. Ybarra performed 11,390 Medicare services across 4,066 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ybarra received a total of $37,671 from 58 pharmaceutical and/or device companies across 1126 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in anesthesiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ybarra is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 0% volume in TX
$37,671 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,390
Medicare services
Top 0% in TX for anesthesiology
4,066
Unique beneficiaries
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~670 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,622 | $0 | $1 |
| Midazolam injection, per 1 mg Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments. |
1,949 | $0 | $1 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,654 | $66 | $266 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,367 | $92 | $376 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
350 | $38 | $149 |
| Injection, methylprednisolone acetate, 40 mg | 346 | $6 | $21 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
260 | $217 | $739 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
218 | $194 | $519 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
213 | $9 | $35 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
192 | $97 | $270 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
187 | $488 | $1,330 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
181 | $82 | $327 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
179 | $143 | $483 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
175 | $222 | $736 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
172 | $53 | $189 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
167 | $86 | $347 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
112 | $0 | $2 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
99 | $119 | $489 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
96 | $209 | $566 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
93 | $43 | $165 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
92 | $197 | $787 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
89 | $104 | $286 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
80 | $45 | $181 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
71 | $64 | $265 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint. |
57 | $228 | $794 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
56 | $88 | $335 |
| Facet joint nerve destruction, single joint This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint. |
56 | $471 | $1,317 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
52 | $192 | $775 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
42 | $10 | $42 |
| Spinal neurostimulator electrode insertion A procedure to place an electrode array into the spine through the skin. The electrode is used to deliver electrical stimulation to the nervous system. |
38 | $1,596 | $7,021 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
28 | $94 | $295 |
| Additional sedation, per 15 minutes Administration of a drug to deepen sedation during a procedure. This code covers each additional 15-minute increment of sedation beyond the initial period. |
25 | $8 | $31 |
| Spinal neurostimulator electrode insertion A procedure to place an electrode array into the spine using fluoroscopic imaging guidance. |
22 | $511 | $2,030 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
22 | $54 | $213 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
17 | $43 | $164 |
| Trigger point injection, 1-2 muscles A procedure involving the injection of medication into one or two specific muscles to treat trigger points. |
11 | $41 | $157 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$37,671
Total received (2018-2024)
Avg $5,382/year across 7 years
Top 1% in TX for anesthesiology
58
Companies
1,126
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$37,671 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,899
2023
$7,771
2022
$4,588
2021
$4,879
2020
$3,493
2019
$6,839
2018
$3,202
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Nevro Corp.
$14,483
Abbott Laboratories
$7,864
PAINTEQ LLC
$1,760
BOSTON SCIENTIFIC CORPORATION
$1,337
Boston Scientific Corporation
$1,254
Teva Pharmaceuticals USA, Inc.
$1,162
Vertiflex, Inc.
$1,052
SI-BONE, Inc.
$993
Nalu Medical, Inc.
$910
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$731
ABBVIE INC.
$493
MML US, Inc.
$358
Amgen Inc.
$352
SPR Therapeutics, Inc
$338
Biohaven Pharmaceuticals, Inc.
$311
Saluda Medical Americas, Inc.
$285
BIOTRONIK NRO, Inc.
$277
SI-BONE, INC.
$254
Zyla Life Sciences
$234
Horizon Therapeutics plc
$202
AbbVie Inc.
$188
Almatica Pharma LLC
$185
Biohaven Pharmaceutical Holding Company Ltd.
$185
Medtronic, Inc.
$179
ASSERTIO THERAPEUTICS, Inc.
$176
Egalet US Inc
$176
Novartis Pharmaceuticals Corporation
$169
Vertos Medical, Inc.
$155
Horizon Pharma plc
$152
Collegium Pharmaceutical, Inc.
$127
Zyla Life Sciences, Inc.
$123
Medtronic USA, Inc.
$117
Stimwave Technologies Incorporated
$107
Assertio Therapeutics, Inc.
$107
Lundbeck LLC
$80
Daiichi Sankyo Inc.
$76
Scilex Pharmaceuticals Inc.
$68
Flowonix Medical Incorporated
$65
Averitas Pharma Inc.
$50
Vertical Pharmaceuticals, LLC
$48
PFIZER INC.
$47
Pernix Therapeutics Holdings, Inc.
$45
ARBOR PHARMACEUTICALS, INC.
$40
Lilly USA, LLC
$38
Azurity Pharmaceuticals, Inc.
$38
Spinal Simplicity, LLC
$37
Sentynl Therapeutics, Inc.
$30
UPSHER-SMITH LABORATORIES LLC
$27
IMPEL PHARMACEUTICALS INC.
$27
GRT US Holding, Inc.
$26
INSYS Therapeutics Inc
$22
IBSA Pharma Inc.
$20
BioDelivery Sciences International, Inc.
$20
US WorldMeds, LLC
$17
Flexion Therapeutics, Inc.
$17
Pacira Pharmaceuticals Incorporated
$13
RedHill Biopharma Inc.
$12
Allergan, Inc.
$12
Top 3 companies account for 64.0% of total payments
Associated products mentioned in payments ›
ADAPTIVESTIM · AIMOVIG · AJOVY · Aimovig · BUNAVAIL 2.1 mg 30-count box · BYSTOLIC · Belbuca · Cambia · DRG IPGs · DUEXIS · EMBLEM MRI S-ICD · EMGALITY · ETERNA · Evoke · GENERAL PAIN MANAGEMENT · GENERAL THERAPIES · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GRALISE · General - Pain Management · General - Therapies · Gralise · HA MINUTEMAN G3-R · HORIZANT · Horizant · IFUSE IMPLANT · INTELLIS · INTELLIS ADAPTIVESTIM · IONICRF · IonicRF Generator · Iovera · LORZONE · LYRICA · Levorphanol · Lucemyra/Lofexidine · METHYLPHENIDATE 72 · Morphabond ER · Movantik · NAPRELAN · NURTEC ODT · Nalu Neurostimulation System · Neuromodulation Dspsbls and Accs · Nucynta · OCTRODE · Omnia · PAINTEQ · PROCLAIM · Prism · Proclaim DRG IPG · Proclaim Family of SCS IPGs · Proclaim IPG · Prometra II · Prospera · Protege Family of SCS IPGs · QULIPTA · QUTENZA · Qutenza · RAYOS · RELISTOR · RELISTOR ORAL · ReActiv8 · SCS leads · SPECTRA WAVEWRITER · SPRINT PNS System · SPRIX · SUBSYS · SUPERION · Senza · Senza Spinal Cord Stimulation System · Superion · Superion ISS · Superion Indirect Decompression System · TOSYMRA · Tirosint · Trudhesa · UBRELVY · VANTA ADAPTIVESTIM · VYEPTI · Vanta · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XTAMPZA · ZIPSOR · ZOHYDRO ER · ZORVOLEX · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · Zipsor · iFuse Implant · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for anesthesiology in TX.
Equivalent to $331 per 100 Medicare services performed
Geographic Context
Anesthesiologists within 10 mi
466
Per 100K population
22.9
County median income
$70,571
Nearest hospital
LAUREL RIDGE TREATMENT CENTER
11.0 mi
11.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ybarra is a clinical cardiology specialist, with above-average Medicare volume (top 0% in TX), with low-engagement industry engagement in the top 1% of TX peers, with 17 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ybarra experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Ybarra performed 2,622 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ybarra receive payments from pharmaceutical companies?
Yes. Dr. Ybarra received a total of $37,671 from 58 companies across 1,126 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ybarra's costs compare to other anesthesiologists in Schertz?
Dr. Ybarra's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ybarra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Anesthesiologists in Schertz
Browse anesthesiologists in Schertz ranked by procedure volume and transparency data.
Highest volume
Top Anesthesiologists in TX
Anesthesiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Anesthesiologists in TX
Which TX anesthesiologists receive the most from drug and device companies.
By company
Nevro Corp. Payments to Doctors
See all physicians who received payments from Nevro Corp.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
PAINTEQ LLC Payments to Doctors
See all physicians who received payments from PAINTEQ LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology